Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · July 01, 2014

3,3-Diphosphono-1,2-Propanodicarboxylic Acid Scintigraphy in Systemic Amyloidosis

European Heart Journal Cardiovascular Imaging

 

Additional Info

European Heart Journal Cardiovascular Imaging
Utility and Limitations of 3,3-Diphosphono-1,2-Propanodicarboxylic Acid Scintigraphy in Systemic Amyloidosis
Eur Heart J Cardiovasc Imaging 2014 Jun 16;[EPub Ahead of Print], DF Hutt, AM Quigley, J Page, ML Hall, M Burniston, D Gopaul, T Lane, CJ Whelan, HJ Lachmann, JD Gillmore, PN Hawkins, AD Wechalekar

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading